Detalles de la búsqueda
1.
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
Trials
; 22(1): 765, 2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732236
2.
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Haematologica
; 93(4): 551-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18379010
Resultados
1 -
2
de 2
1
Próxima >
>>